These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38279329)

  • 1. The Microbiota in Long COVID.
    Álvarez-Santacruz C; Tyrkalska SD; Candel S
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome.
    Moreno-Corona NC; López-Ortega O; Pérez-Martínez CA; Martínez-Castillo M; De Jesús-González LA; León-Reyes G; León-Juárez M
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
    Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Microbiome in the Pathogenesis of COVID-19.
    De R; Dutta S
    Front Cell Infect Microbiol; 2022; 12():736397. PubMed ID: 35433495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review.
    Zhu T; Jin J; Chen M; Chen Y
    Virulence; 2022 Dec; 13(1):1076-1087. PubMed ID: 35763685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
    Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
    Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
    Tieu V; Tibi S; Ling J
    Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between immune system and microbiota in COVID-19.
    Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
    Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
    World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
    Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
    Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.